For Research Purposes Only

Peter Attia on Ipamorelin

Peter Attia has publicly discussed Ipamorelin on multiple occasions. Peter Attia discusses GH peptides within a risk-benefit framework, noting the theoretical concerns about IGF-1 elevation and cancer risk with compounds promoting cell growth. This page examines what Peter Attia said, the specific sources, and how these statements compare to the available research.

"Growth hormone optimization requires understanding the full context of what we're trying to achieve and what risks we're accepting."

Peter AttiaThe Drive podcast

What Peter Attia Discussed

Discusses GH peptides within a risk-benefit framework, noting the theoretical concerns about IGF-1 elevation and cancer risk with compounds promoting cell growth.

Dosage Mentioned

Discussed cautiously in longevity context

What Research Shows About Ipamorelin

+Selective GH release without cortisol elevation
+Supports muscle protein synthesis
+May enhance sleep quality via nocturnal GH
+Favorable side-effect profile

How Ipamorelin Works

Ipamorelin binds to ghrelin receptors on pituitary somatotrophs, selectively stimulating growth hormone release without significantly affecting cortisol, ACTH, or prolactin. This selectivity makes it one of the cleanest GH secretagogues.

Research Summary

Phase 2 trials confirm selective GH release with favorable side-effect profile. Studied for post-operative ileus recovery. Well-characterized selectivity.

Standard Dosage Information

Community protocols: 200-300mcg subcutaneously 2-3 times daily on empty stomach. Often combined with CJC-1295. Best taken before bed.

Important Considerations

  • !Peter Attia discussed this peptide from personal experience or professional perspective, not as medical advice
  • !Individual responses vary based on health status and genetics
  • !Always consult a healthcare professional before any peptide protocol
  • !FDA has flagged concerns with compounding pharmacies

Frequently Asked Questions

What has Peter Attia said about Ipamorelin?

Peter Attia has publicly discussed Ipamorelin in interviews, podcasts, or social media. Their comments reflect personal experience or professional observations, not medical recommendations. See the quotes and sources above for specific statements.

Should I follow Peter Attia's Ipamorelin protocol?

Celebrity protocols are not medical advice. Peter Attia's experience with Ipamorelin is individual and may not apply to your health situation. Always consult a qualified healthcare professional before considering any peptide protocol.

Is Ipamorelin safe based on what Peter Attia has discussed?

Peter Attia's positive experience does not establish safety. Ipamorelin's safety profile depends on the specific compound, dosing, individual health status, and potential drug interactions. Celebrity experiences cannot replace clinical evidence and medical supervision.

Other Peptides Peter Attia Has Discussed

Legal Disclaimer: This page documents what Peter Attia has publicly discussed regarding Ipamorelin. This information is for educational and research purposes only. Ipamorelin is not FDA-approved for the uses discussed. Celebrity experiences are individual and do not constitute clinical evidence. Always consult qualified healthcare professionals before considering any peptide protocol.